These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 91955)
21. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea. Ellis JL; Conanan ND J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355 [TBL] [Abstract][Full Text] [Related]
22. Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs. Nedoma J; Tucek S; Danilov AF; Shelkovnikov SA J Pharmacol Exp Ther; 1986 Jan; 236(1):219-23. PubMed ID: 3941394 [TBL] [Abstract][Full Text] [Related]
23. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor. Olianas MC; Maullu C; Onali P Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494 [TBL] [Abstract][Full Text] [Related]
24. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma. Johnson HG; Sheridan AQ Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630 [TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Dunlap J; Brown JH Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150 [TBL] [Abstract][Full Text] [Related]
26. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms. Evans T; Smith MM; Tanner LI; Harden TK Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892 [TBL] [Abstract][Full Text] [Related]
27. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases. Bergstrand H; Kristoffersson J; Lundquist B; Schurmann A Mol Pharmacol; 1977 Jan; 13(1):38-43. PubMed ID: 189182 [No Abstract] [Full Text] [Related]
33. [Drugs inhibiting chemical mediator release as remedies for allergy-related diseases]. Koda A Nihon Hifuka Gakkai Zasshi; 1985 Oct; 95(12 Suppl):1293-6. PubMed ID: 2422416 [No Abstract] [Full Text] [Related]
34. Inhibition of allergic reactions by cromoglycate and by a new antiallergy drug U-42,585E. II. Activity in primates against aerosolized Ascaris suum antigen. Johnson HG; VanHout CA; Wright JB Int Arch Allergy Appl Immunol; 1978; 56(6):481-7. PubMed ID: 415987 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of oxidative enzymes by anti-allergy drugs. White GJ Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476 [TBL] [Abstract][Full Text] [Related]
36. Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm. Ungerer RG; Tashkin DP; Siegel SC; Deutsch RI J Allergy Clin Immunol; 1981 Dec; 68(6):471-8. PubMed ID: 7310012 [TBL] [Abstract][Full Text] [Related]
37. Biphasic effects of 3-quinuclidinyl benzilate on spontaneous motor activity in mice. Liu WF; Hu NW; Beaton JM Psychopharmacology (Berl); 1984; 84(4):486-8. PubMed ID: 6441949 [TBL] [Abstract][Full Text] [Related]